Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Federal University of Minas Gerais
Researchers from Brazil, Italy and Portugal provide details of new studies and findings in the area of obesity
June 23rd, 2006
New findings from Brazil, Italy and Portugal describe advances in obesity. Study 1: Botulinum A toxin injected into the gastric wall was a safe treatment option for class III obesity. "Obesity represents a major public health problem in western countries. Initial studies suggest that injection of botulinum A toxin (Btx-A) into the antropyloric region inhibits propulsive contractions of the antral pump, with delay in gastric emptying, early satiety and weight loss," investigators in Brazil report. A. Cardoso and colleagues working with the Federal University of Minas Gerais explained, "After approval by the University Ethics...
Source: Biotech Law Weekly (2006-06-23)
|
